Cataract Devices Market Estimated at USD 14.68 Billion in 2025 | Key Players: Johnson & Johnson; Carl Zeiss Meditec AG; Bausch & Lomb; Hoya Corporation; Staar Surgical

The global Cataract Devices Market is valued at approximately USD 14.68 billion in 2025, reflecting strong demand for cataract treatment devices driven by a rising incidence of visual impairment from cataracts. The aging population globally, especially in regions with under-served eye care infrastructure, is compelling healthcare systems to scale up surgical volume and adopt more advanced devices.

Demand is rising not just for traditional phacoemulsification equipment but also for premium intraocular lenses (IOLs) and vision correction technologies, as patients increasingly expect both restoration and enhancement of vision.

Full Market Report Available for Delivery. For Purchase or Customization, Please Request Here: https://www.factmr.com/connectus/sample?flag=S&rep_id=7840

Cataract Devices Market Forecast to Reach USD 21.28 Billion by 2035:

Between 2025 and 2035, the cataract devices market is projected to grow at a compound annual growth rate (CAGR) of about 3.8%, reaching around USD 21.28 billion by 2035. This growth trajectory is supported by technological innovations, increasing access to surgery in emerging economies, and stronger reimbursement and public health initiatives to reduce surgery backlogs. Key product areas such as femtosecond laser-assisted surgery and advanced premium IOLs (multifocal, toric) are expected to contribute significantly to revenue growth as surgeons and patients opt for more precise, less invasive, and more visually satisfying outcomes.

Market Drivers: Technology, Demographics & Policy:

The growth of the Cataract Devices Market is underpinned by multiple factors. First, demographic shifts, particularly in countries with growing elderly populations, are increasing the prevalence of cataracts, propelling surgical demand. Second, patients' expectations are evolving: there is growing preference not just for restoring vision but reducing dependence on spectacles post-surgery, which has spurred demand for premium IOLs, such as multifocal and toric lenses.

Third, technological advances-image-guided systems, femtosecond lasers, improved intraoperative visualization, AI-assisted surgical planning-are improving safety, surgical precision, and recovery times. Fourth, there is policy momentum: governments and public health bodies are investing in cataract screening, flexible surgical programs, and partnerships to improve surgical access in rural or underserved regions, which broadens the market beyond wealthy or urban settings.

Key Segmentation & Regional Trends:

By product type, the market includes phacoemulsification equipment, ophthalmic viscoelastic devices (OVD), intraocular lenses, and femtosecond lasers. Among these, IOLs-particularly premium IOLs-are a major contributor, while phacoemulsification systems remain indispensable for the core surgical procedure. By application, types of cataracts treated include nuclear sclerotic, posterior sub-capsular, cortical, congenital, and traumatic cataracts. Nuclear sclerotic cataracts represent a large share (about 28% in 2025), reflecting age-related incidence.

By end user, hospitals dominate due to their infrastructure and capacity to handle complex cases, while ophthalmic clinics and ambulatory surgery centers are growing in importance, particularly in regions seeking faster, lower-cost surgical routes and greater access. Regionally, China stands out as the fastest-growing market (CAGR ~6.1%), while the United States grows at ~5.6%. Other countries such as Germany, Japan, South Korea and in Europe (UK, France) are expected to see steady growth in line with aging populations and high expectations for premium visual outcomes.

Recent Developments:

Recent trends in the Cataract Devices Market show increasing adoption of minimally invasive surgery and premium lenses. Femtosecond laser assisted cataract surgery is becoming more common in higher-income markets, often paired with premium IOLs to enable better post-surgery visual acuity and reduced dependence on corrective glasses. AI-assisted tools and surgical planning software are being integrated to improve precision and predictability of outcomes. Ambulatory Surgical Centers (ASCs) and outpatient surgery facilities are rising in number, creating demand for smaller, more portable surgical equipment.

There is also a push toward designing devices that are more cost-effective and sustainable, especially for high-volume surgical programs in emerging economies. Public health initiatives and non-profit partnerships are working to reduce the backlog of untreated cataracts, particularly in rural or low-resource settings.

Key Players Insights:

Major corporations play a crucial role in shaping the Cataract Devices Market. Some of the leading companies are Johnson & Johnson, Carl Zeiss Meditec AG, Bausch & Lomb, Hoya Corporation, Staar Surgical, NIDEK CO., LTD, Aurolabs, Biotech Healthcare Group, Ophtec BV, VSY Biotechnology BV, and Ziemer Ophthalmic Systems AG.

These firms are distinguished by their R&D investments in premium intraocular lenses, advanced surgical systems (including lasers), device miniaturization, and AI/precision features. For instance, multifunctional premium IOLs, femtosecond laser platforms, and imaging/visualization enhancements are areas where these companies compete to differentiate. Also, many are expanding geographically into Asia-Pacific and Latin America, often via partnerships or customized product offerings better suited to local clinical and economic conditions.

Challenges & Market Restraints:

Despite the promising outlook, the Cataract Devices Market faces several challenges. Access to surgery remains uneven, especially in low- and middle-income countries where infrastructure, trained personnel, regulatory pathways, and reimbursement are more limited. Device cost, particularly for premium lenses and laser systems, can be a barrier for both providers and patients. There are also quality and safety concerns; regulatory standards differ by country, and ensuring consistent outcomes across diverse surgical settings is difficult. Surgical training and surgeon experience can affect outcomes, especially with newer technologies.

Also, logistical challenges in supply chain, device servicing, and maintenance, especially in remote or rural areas, can limit adoption. Lastly, ensuring that innovations (e.g., AI, laser systems) deliver meaningful patient benefit without adding undue cost is critical for wider acceptance.

Browse Full Report: https://www.factmr.com/report/cataract-devices-market

Future Outlook:

Looking toward 2035, the Cataract Devices Market is expected to evolve with more personalized, patient-centric solutions. Premium IOLs (toric, multifocal, accommodative) will likely become more accessible, both through technology improvements and cost reductions. Surgeons will increasingly adopt image-guided systems and intraoperative diagnostics to enhance outcomes. The trend toward outpatient cataract surgery and surgical centers with lower overhead will shape demand for more compact, efficient devices. Regions like Asia-Pacific are likely to see large absolute growth, while mature markets will push for greater precision, better vision outcomes, and less postoperative dependency on glasses.

Sustainability and affordability will become more central in product design and health policy. With the market expected to reach about USD 21.28 billion by 2035 from USD 14.68 billion in 2025 at a CAGR of ~3.8%, the cataract devices market is set for steady growth, shaped by innovation, demographic trends, and expanding access to eye care.

Check out More Related Studies Published by Fact.MR:

IVF Devices Market: https://www.factmr.com/report/ivf-devices-market

ENT Devices Market: https://www.factmr.com/report/ent-devices-market

Spine Devices Market: https://www.factmr.com/report/259/spine-devices-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.